Researchers have spent more than three decades developing and studying miniature biosensors that can identify single molecules. In 5 to 10 years, when such devices may become a staple in doctors' offices, they could detect molecular markers for cancer and other diseases and assess the effectiveness of drug treatment to fight those illnesses.